1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Transient Lipid-Protein Structures and Selective Ganglioside Uptake During α-Synuclein-Lipid Co-aggregation
(
- Contribution to journal › Article
- 2020
-
Mark
The role of fibril structure and surface hydrophobicity in secondary nucleation of amyloid fibrils
2020) In Proceedings of the National Academy of Sciences of the United States of America 117(41). p.25272-25283(
- Contribution to journal › Article
-
Mark
Direct measurement of lipid membrane disruption connects kinetics and toxicity of Aβ42 aggregation
(
- Contribution to journal › Article
- 2019
-
Mark
A method of predicting the in vitro fibril formation propensity of Aβ40 mutants based on their inclusion body levels in E. coli
(
- Contribution to journal › Article
-
Mark
Trodusquemine enhances Aβ42 aggregation but suppresses its toxicity by displacing oligomers from cell membranes
(
- Contribution to journal › Article
- 2018
-
Mark
On the role of sidechain size and charge in the aggregation of Aβ42 with familial mutations
2018) In Proceedings of the National Academy of Sciences of the United States of America 115(26). p.5849-5858(
- Contribution to journal › Article
- 2017
-
Mark
Selective targeting of primary and secondary nucleation pathways in Ab42 aggregation using a rational antibody scanning method
(
- Contribution to journal › Article
- 2016
-
Mark
Molecular mechanisms of protein aggregation from global fitting of kinetic models.
(
- Contribution to journal › Article
-
Mark
An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease.
(
- Contribution to journal › Article
- 2002
-
Mark
Protein reconstitution and 3D domain swapping.
(
- Contribution to journal › Scientific review